Franziska Blaeschke
Dr. Von Hauner'sches Kinderspital
Munich, BY 80337, Germany
Munich, BY 80337, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Advances in cell therapy: progress and challenges in hematological and solid tumors.
Journal: Trends in pharmacological sciences
Published: August 12, 2024
Modular pooled discovery of synthetic knockin sequences to program durable cell therapies.
Journal: Cell
Published: June 25, 2022
CRISPR activation and interference screens decode stimulation responses in primary human T cells.
Journal: Science (New York, N.Y.)
Published: February 03, 2022
Design and Evaluation of TIM-3-CD28 Checkpoint Fusion Proteins to Improve Anti-CD19 CAR T-Cell Function.
Journal: Frontiers in immunology
Published: December 29, 2021
Robust T cell activation requires an eIF3-driven burst in T cell receptor translation.
Journal: eLife
Published: September 28, 2021
RASA2 ablation in T cells boosts antigen sensitivity and long-term function.
Journal: Nature
Published: July 31, 2021
Augmenting anti-CD19 and anti-CD22 CAR T-cell function using PD-1-CD28 checkpoint fusion proteins.
Journal: Blood cancer journal
Published: March 24, 2021
Protective T cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 03, 2021
Targeted delivery of CRISPR-Cas9 and transgenes enables complex immune cell engineering.
Journal: Cell reports
Published: November 23, 2020
Last Updated: 09/26/2026